Gain Therapeutics (GANX) Proxy filing summary

Executive summary

• Annual Meeting of Stockholders scheduled for June 24, 2026, at 8:30 a.m. Eastern Time in New York.

• Proxy materials are available online, with options to request paper or email copies by June 10, 2026.

• Stockholders can vote online, by mail, by telephone, or in person at the meeting.

Voting matters and shareholder proposals

• Proposal 1: Election of seven directors—Gene Mack, Khalid Islam, Dov Goldstein, Hans Peter Hasler, Gwen Melincoff, Claude Nicaise, and Jeffrey Riley.

• Proposal 2: Ratification of Ernst & Young AG as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Board recommends voting "FOR" all director nominees and "FOR" the auditor ratification.

• Additional business may be conducted if properly brought before the meeting.

Board of directors and corporate governance

• Seven director nominees are presented for election at the annual meeting.